Big Data Analysis in the Pharmaceutical Industry: The Case for Multivariate Analysis
Posted on January 9, 2019
Mike Tobyn, Research Fellow, Drug Product Science and Technology
Bristol-Myers Squibb
Ana Patricia Ferreira, Principal Scientist, Drug Product Science and Technology
Bristol-Myers Squibb
Jose´ C. Menezes, Professor
Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Lisboa, Portugal
Abstract The Pharmaceutical Industry has a strong need to develop knowledge from data. Although the latter is not at a premium in the Pharmaceutical Industry the former is, as always, at a premium. Multivariate data analysis (MVA) is a set of statistical data analytical methods which has been widely...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Big Data Analysis, multivariate analysis, MVA, statistical data analytical methods
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
